Citation: Sa. Dekowski et Rb. Holtzman, SURFACTANT REPLACEMENT THERAPY - AN UPDATE ON APPLICATIONS, The Pediatric clinics of North America, 45(3), 1998, pp. 549
Authors:
BRANDSTATTER IM
MORRIS LR
JOHNSON MD
HOLTZMAN RB
Citation: Im. Brandstatter et al., RECOVERY FROM BUTYLATED HYDROXYTOLUENE O-2 INDUCED LUNG FIBROSIS INCREASED MATRIX METALLOPROTEINASE-9 ACTIVITY AND DAMAGE TO TYPE-IV COLLAGEN/, Pediatric research, 37(4), 1995, pp. 327-327
Authors:
HOLTZMAN RB
BRANDSTATTER IM
MORRIS LR
JOHNSON MD
Citation: Rb. Holtzman et al., STROMELYSIN ACTIVITY IS INCREASED IN REPAIRING MOUSE LUNGS COMPARED TO FIBROTIC LUNGS, Pediatric research, 37(4), 1995, pp. 336-336
Authors:
MORRIS LR
BRANDSTATTER IM
JOHNSON MD
HOLTZMAN RB
Citation: Lr. Morris et al., DEXAMETHASONE REDUCES MATRIX METALLOPROTEINASE-9 ACTIVITY AND ATTENUATES BASEMENT-MEMBRANE DAMAGE IN BUTYLATED HYDROXYTOLUENE O-2 INDUCED LUNG FIBROSIS IN THE MOUSE, Pediatric research, 37(4), 1995, pp. 343-343
Authors:
HOLTZMAN RB
FELDMAN I
PARR L
LEIBOVICH SJ
Citation: Rb. Holtzman et al., NO SPECIFIC CHANGES IN STEADY-STATE MESSENGER-RNA EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA-1 (TGF-BETA-1) OR PLATELET-DERIVED GROWTH FACTOR-B (PDGF-B) IN MOUSE LUNGS DURING BUTYLATED HYDROXYTOLUENE-INDUCED LUNG FIBROSIS, The American review of respiratory disease, 147(4), 1993, pp. 421-421